Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

87.5%

+1.0% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

71%

5 of 7 completed trials have results

Key Signals

5 with results

Enrollment Performance

Analytics

N/A

7(87.5%)

Phase 4

1(12.5%)

8Total

N/A(7)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT00487552Not ApplicableTerminated

Magnetic Anastomosis Device Relief of Malignant Gastric Outlet Obstruction

Role: collaborator

NCT00526487Not ApplicableCompleted

Clinical Study to Assess Safety and Effectiveness of the Zenith® Dissection Endovascular System in Patients With Aortic Dissection

Role: collaborator

NCT00470626Not ApplicableCompleted

Celect Vena Cava Filter Clinical Trial

Role: collaborator

NCT00393887Not ApplicableCompleted

Inguinal Hernia Study Using Biodesign IHM

Role: collaborator

NCT00274625Not ApplicableCompleted

Evaluation of Surgisis Gold Graft for Incision Reinforcement After Open Bariatric Surgery

Role: collaborator

NCT00111176Not ApplicableCompleted

STARZ-TX2 Clinical Study: Study of Thoracic Aortic Aneurysm Repair With the Zenith TX2 Endovascular Graft

Role: collaborator

NCT00120406Not ApplicableCompleted

Evaluation of the Zilver PTX Drug-Eluting Stent in the Above-the-Knee Femoropopliteal Artery

Role: collaborator

NCT00374270Phase 4Completed

Improving Blood Pressure Management in Patients With Diabetes

Role: collaborator

All 8 trials loaded